Microbix Reports Record Product Sales for Q4 and Fiscal 2024

by Shitika Kulshreshtha | Dec 19, 2024 | Blog, Media Features News Releases, News Releases

Full-Year Revenues of $25.4 million and Net Income of $3.5 million MISSISSAUGA, CANADA, December 19, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year...

Microbix Schedules Release of Results for Q4 Fiscal 2024

by Shitika Kulshreshtha | Dec 12, 2024 | Blog, Media Features News Releases, News Releases

Results Release and Webinar Discussion on Morning of December 19, 2024 MISSISSAUGA, CANADA, December 12, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file...

Microbix Assisting EMQN with Novel Genetic-Test EQA Program

by Shitika Kulshreshtha | Dec 10, 2024 | Blog, Media Features News Releases, News Releases

For Rapid Identification of Patients Susceptible to Antibiotic-Induced Hearing Loss MISSISSAUGA, CANADA & MANCHESTER, UK – December 10, 2024 –  Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and...

Microbix Announces Initiation of Normal Course Issuer Bid

by Shitika Kulshreshtha | Dec 5, 2024 | Blog, Media Features News Releases, News Releases

For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 5, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter,...

KOL Collaborators Present Microbix HPV Test-Control Results

by Shitika Kulshreshtha | Nov 12, 2024 | Blog, Media Features News Releases, News Releases

Validation for use with Self-Collected Samples across Multiple Assays and Media MISSISSAUGA, CANADA, November 12, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that key...

Microbix Presents Novel HSV Test Control at EMMD

by Shitika Kulshreshtha | Oct 7, 2024 | Blog, Media Features News Releases, News Releases

IVDR Compliance and CE Certifications for REDx™ QAPs MISSISSAUGA, CANADA, October 7, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a novel...